Treatment of terminal peritoneal carcinomatosis by a transducible p53-activating peptide

Authors

Eric L. Snyder, Howard Hughes Medical Institute
Bryan R. Meade, University of California - San Diego
Cheryl C. Saenz, Howard Hughes Medical Institute
Steven F. Dowdy, Howard Hughes Medical InstituteFollow

Journal

PLOS Biology

Publication Date

2004

Volume

2

Issue

2

Inclusive Pages

186-193

Document Type

Open Access Publication

DOI

10.1371/journal.pbio.0020036

Rights and Permissions

Snyder EL, Meade BR, Saenz CC, Dowdy SF, 2004 Treatment of Terminal Peritoneal Carcinomatosis by a Transducible p53-Activating Peptide. PLoS Biol 2(2): e36. doi:10.1371/journal.pbio.0020036

Recommended Citation

Snyder, Eric L.; Meade, Bryan R.; Saenz, Cheryl C.; and Dowdy, Steven F., "Treatment of terminal peritoneal carcinomatosis by a transducible p53-activating peptide." PLOS Biology. 2, 2. 186-193. (2004).
https://digitalcommons.wustl.edu/open_access_pubs/322